HOMA-IR in acromegaly: a systematic review and meta-analysis.

Betina BiagettiAnna AulinasAnna CasterasSantiago Pérez-HoyosRafael Simó

Published in: Pituitary (2020)

HOMA-IR in treatment-naïve ACRO patients is higher than in the reference population, even in patients without diabetes. This finding, confirms that insulin resistance is an early event in ACRO. Our results also suggest that HOMA-IR is not an adequate tool for assessing insulin resistance in those patients treated with SSAs.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
insulin resistance
newly diagnosed
type diabetes
prognostic factors
cardiovascular disease
patient reported outcomes
polycystic ovary syndrome
glycemic control
weight loss